Related Experiment Video
Updated: Jun 28, 2026

A Retrospective Study on Endoscopic Surgery for the Treatment of Paravertebral Abscess in Spinal Tuberculosis Patients
Published on: October 25, 2024
Tuberculosis Patients' Preferences for Improving Tuberculosis Care in Chitwan District, Nepal: A Discrete Choice
Tara Prasad Aryal1, Kedar Prasad Baral1, Jeevan Thapa1
1School of Public Health, Patan Academy of Health Sciences, Lalitpur, Bagmati, Nepal.
Objectives:
Patient-preferred tuberculosis (TB) care is integral for the patient-centric approach to TB care delivery. This study aimed to ascertain the aspects of TB care that people with TB value most, to inform improvements in TB care in Chitwan District, Nepal.
Methods:
A discrete choice experiment (DCE) survey was developed to elicit the care preferences of TB patients in Chitwan District. The DCE included 6 attributes (patient card, sex of healthcare worker, transport incentive, provision of psychosocial support, waiting time, and type of TB care provider), which were developed through literature review, expert consultations, and patient interviews. Participants were randomly selected from the TB care centers and interviewed face-to-face to complete the survey. Six choice sets were presented to each participant and asked to choose preferred option from 2 hypothetical TB care models labeled as TB Care A and TB Care B. A conditional logit regression model was used to quantify the preference of TB patients.
Results:
Among 133 patients who participated in DCE (97% response rate, mean age of 47 years, 71% male), 83% had pulmonary bacteriologically confirmed TB, and 32% were in the intensive phase of treatment. Patients highly valued TB care services that have the provision of psychosocial support (β = 0.62, P < .001), followed by improved patient card (β = 0.50, P < .001), and the waiting time for TB care within half an hour (β = 0.25, P = .002).
Conclusions:
People with TB preferred to be supported by psychosocial interventions, improved patient card, and reduced waiting time in current TB treatment strategy. This study provides evidence for current/future TB control program package to align with the patient's preferences.
Related Concept Videos
Pulmonary Tuberculosis V
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the progression...
Pulmonary Tuberculosis I
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
Pulmonary Tuberculosis II
Here is a detailed explanation of its pathophysiology:
Transmission: The process begins when a person inhales droplet nuclei containing M. tuberculosis. These are typically released into the air when an individual with pulmonary or...
Pulmonary Tuberculosis IV
Several diagnostic approaches are used to detect TB. The conventional method is the Tuberculin Skin Test (TST), also known as the Mantoux test. However, this method has...
Pulmonary Tuberculosis III
The first classification is based on the development of the disease, and it includes the following categories:
Tuberculosis